Company

SYNAPS Dx - An Alzheimer's Diagnostic company

Biotechnology 12441 Parklawn Dr 21 employees NMTC

Employees: 21
Contacts: 4
Emails: 4

www.synapsdx.com LinkedIn Crunchbase

SYNAPS Dx - An Alzheimer's Diagnostic company Overview

Headquarters: 12441 Parklawn Dr
Website: www.synapsdx.com
Industry: Biotechnology
Employees: 21
Founded: 2016
Stock Symbol: NMTC

Keywords

New York

About SYNAPS Dx - An Alzheimer's Diagnostic company

Synaps Dx is dedicated to transforming the diagnosis of Alzheimer’s disease (AD). Operating a CLIA-certified laboratory, we offer DISCERN™, the first commercially available test to accurately detect AD (>95%). info@synapsdx.com Granted Breakthrough Status by the FDA, DISCERN™ provides a convenient, accurate, minimally invasive diagnosis of Alzheimer’s disease. Through analysis of one (1) small in-office skin biopsy provided by a referring physician, SDx offers a reliable and accurate alternative to traditional diagnostic methods. Our diagnostic biomarkers have been confirmed by neuropathological validation (NIH “Gold Standard”).

SYNAPS Dx - An Alzheimer's Diagnostic company Contact Details

People in AeroLeads: 4
With contact data: 4
Email contacts: 4; 100.0% coverage

SYNAPS Dx - An Alzheimer's Diagnostic company Org Chart

Sample employees and titles

Name	Title	Location	Contact
Michael Gorton	Investor, 15x Entrepreneur, Teladoc Founder, Visionary Innovator/disrupter, Entrepreneur of the Year, Bestselling Author & Adventurer. I Build	Dallas-fort Worth Metroplex, United States	Email
Dave Rosa	President and CEO at Neuroone Medical Technologies Corp. (Nasdaq: Nmtc)	Eden Prairie, Minnesota, United States	Email
Kathryn Diskin	Leading with People. Driving Operational Success. Building Stronger Workplaces.	New York, United States	Email
Michael Maddox	Bench Scientist	Baltimore, Maryland, United States	Email